FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sykes, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sykes, M.

The FASEB Journal, Vol 10, 721-730, Copyright © 1996 by The Federation of American Societies for Experimental Biology

REVIEWS

Immunobiology of transplantation

M Sykes
Transplantation Biology Research Center, Harvard Medical School, Boston, 02129, USA.

Despite major advances resulting from the development of new immunosuppressive drugs in recent years, the field of clinical transplantation is currently limited by inadequate organ availability, chronic rejection, and complications of chronic, nonspecific immunosuppressive therapy. Because of the organ shortage, extensive research has recently focused on the potential to use donors from other species, i.e., xenotransplantation. The best way to avoid the problems of chronic rejection and complications of immunosuppressive therapy, and to overcome the considerable immunologic barriers to xenotransplantation, would be to induce a state of systemic tolerance to the donor in the recipient. Recent developments in the understanding of mechanisms of central and peripheral T cell tolerance have led to new strategies for inducing tolerance in experimental models, some of which are already being evaluated clinically.


This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
R. Arnon and R. Aharoni
Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications
PNAS, October 5, 2004; 101(suppl_2): 14593 - 14598.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
P. F. Jorgensen, J. E. Wang, M. Almlof, C. Thiemermann, S. J. Foster, R. Solberg, and A. O. Aasen
Peptidoglycan and Lipoteichoic Acid Modify Monocyte Phenotype in Human Whole Blood
Clin. Vaccine Immunol., May 1, 2001; 8(3): 515 - 521.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Qin, Y. Ding, H. Tahara, and J. S. Bromberg
Viral IL-10-Induced Immunosuppression Requires Th2 Cytokines and Impairs APC Function Within the Allograft
J. Immunol., February 15, 2001; 166(4): 2385 - 2393.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Shimizu, U. Schonbeck, F. Mach, P. Libby, and R. N. Mitchell
Host CD40 Ligand Deficiency Induces Long-Term Allograft Survival and Donor-Specific Tolerance in Mouse Cardiac Transplantation But Does Not Prevent Graft Arteriosclerosis
J. Immunol., September 15, 2000; 165(6): 3506 - 3518.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
A. A. ROSSINI, D. L. GREINER, and J. P. MORDES
Induction of Immunologic Tolerance for Transplantation
Physiol Rev, January 1, 1999; 79(1): 99 - 141.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
A. W. FLAKE and E. D. ZANJANI
In Utero Transplantation for Thalassemia
Ann. N.Y. Acad. Sci., June 30, 1998; 850(1): 300 - 311.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by The Federation of American Societies for Experimental Biology.